Wissenschaftliche Arbeiten

Doç. Dr. Nalan Akgül Babacan

63 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Telli, T. A., Demircan, N. C., Alan, O., Tuylu, T. B., Arikan, R., Ercelep, O., R Ergelen, IE Seven, NA Babacan ... & Kaya, S. (2020). A rare case of primary rectal choriocarcinoma and review of the literature. Journal of Oncology Pharmacy Practice, 26(4), 989-994.

    Quelle: Profilseite auf medicana.com.tr

  2. Ercelep, O., Alan, O., Telli, T. A., Tuylu, T. B., Arıkan, R., Demircan, N. C., ET Simsek, NA Babacan ... & Bozkurtlar, E. (2020). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal, 0300891620950475.

    Quelle: Profilseite auf medicana.com.tr

  3. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., S Kaya, NA Babacan ... & Bayri, Y. (2020). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 1078155220920684.

    Quelle: Profilseite auf medicana.com.tr

  4. Robinson, L. A., Babacan, N. A., Tanvetyanon, T., Henderson-Jackson, E., Bui, M. M., & Druta, M. (2020). Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas. The Journal of Thoracic and Cardiovascular Surgery.

    Quelle: Profilseite auf medicana.com.tr

  5. Babacan, N. A., & Eroglu, Z. (2020). Treatment options for advanced melanoma after anti-PD-1 therapy. Current Oncology Reports, 22(4), 1-8.

    Quelle: Profilseite auf medicana.com.tr

  6. Babacan, N. A., Peguero, E., Forsyth, P., & Eroglu, Z. (2021). BRAF Inhibitor Therapy‐Related Encephalitis in a Patient with Metastatic Melanoma. The Oncologist, 26(10), e1887-e1889.

    Quelle: Profilseite auf medicana.com.tr

  7. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., Kaya, S., Babacan, N.A., Atasoy, B.M., Bozkurt, S. Bayri, Y.& Yumuk, P. F. (2021). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 27(2), 329-339.

    Quelle: Profilseite auf medicana.com.tr

  8. Ercelep, O., Alan, O., Telli, T. A., Tuylu, T. B., Arıkan, R., Demircan, N. C., Simsek, E.T., Babacan, N.A., Kaya, S., Dane, F., Bozkurtlar, E. & Yumuk, P. F. (2021). Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma. Tumori Journal, 107(3), 231-237.

    Quelle: Profilseite auf medicana.com.tr

  9. Yildiz, F., Demirci, U., Küçükarda, A., Büyüksimsek, M., Sakalar, T., Topcu, T. O., Aslan, F., Tufan, G., Aydin, O., Turna, H. Babacan, N.A., Paydas, S. (2021). Merkel cell carcinoma in Turkey: A multicentric study. Journal of cancer research and therapeutics, 17(6), 1525.

    Quelle: Profilseite auf medicana.com.tr

  10. Alan, O., Telli, T. A., Tuylu, T. B., Arikan, R., Demircan, N. C., Ercelep, O., Kaya, S., Babacan, N.A., Atasoy, B.M., Bozkurt, S. and Bayri, Y., Yumuk, P. F. (2021). Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience. Journal of Oncology Pharmacy Practice, 27(2), 329-339.

    Quelle: Profilseite auf medicana.com.tr

  11. Bahar-Ozdemir, Yeliz, Sefik Kaya, Nalan Akgul Babacan, Tugce Al, Ece Albayrak, Nilufer Coskun, and Gulseren Akyuz. "Can assessment of disease burden and quality of life based on mobility level in patients with end-stage cancer provide an insight into unmet needs? An exploratory cross-sectional study." Physiotherapy Theory and Practice (2022): 1-11.

    Quelle: Profilseite auf medicana.com.tr

  12. Eroglu Z, Broman KK, Thompson JF,...Nalan Akgul Babacan, Younchul Kim, Mahrukh Naqvi, Jonathan Zager, Nikhil I Khushalani. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection Journal for ImmunoTherapy of Cancer 2022;10:e004417. doi: 10.1136/jitc-2021-004417

    Quelle: Profilseite auf medicana.com.tr

  13. Akin Telli, T., Ozturk, M.A., Alan, O., Hasanov, R., Kostek, O., Arikan, R., Basoglu, T., Kaya, S., Ercelep, O., Akgul Babacan, N. and Dane, F., 2022. Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy. Future Oncology, 18(22), pp.2425-2439.

    Quelle: Profilseite auf medicana.com.tr